Clinical Trial Update: Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

View source ↗

Summary

A clinical trial update describing the use of next-generation sequencing to analyze the peripheral blood immune repertoire in Graves' disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Graves Disease | Status: UNKNOWN